David Grainger

David Grainger

University of Utah, USA

Prof. David W. Grainger is a University Distinguished Professor and Department Chair and Professor of Bioengineering, and Professor of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah, USA.

Prof. Grainger’s research focuses on improving drug delivery methods, implanted medical device and clinical diagnostics performance, and nanomaterials toxicity. 

Prof. Grainger has published ~200 research papers and 30 book chapters on biomaterials innovation in medicine and biotechnology, and novel surface and diagnostics chemistry.  His research awards include a 2016 Fulbright Scholar Award (New Zealand), the 2013 Excellence in Surface Science Award (Surfaces in Biomaterials Foundation), the 2007 Clemson Award for Basic Research (Society for Biomaterials), and the 2005 American Pharmaceutical Research and Manufacturer’s Association’s award for “Excellence in Pharmaceutics”. Prof. Grainger has served as Chair of several prominent USA research review panels and now serves on the NIH NIBIB Council.  He serves on the editorial boards for 6 major journals, past handling editor for the journal, Biomaterials, for nearly two decades, and a special topics editor for Advanced Drug Delivery Reviews.  He has co-organized nearly 30 international symposia.  Prof. Grainger is recognized with numerous prominent teaching awards and has provided over 370 invited lectures and outreach workshops globally. 

He consults widely for the biomedical device and pharmaceutical industry and has been a principal in 6 biotech start-ups, some with successful commercialization efforts with marketed products.  Grainger continues to emphasize translational approaches to clinical biomaterials, and validation of clinical effectiveness in implants and drug delivery systems for value-based medicine.  His leadership is sought in his official Scientific Advisory Board roles on several international medical technology research consortia.